Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kura Oncology
Kura Oncology
Kura files $100m offer after menin inhibitor results in AML
Pharmaphorum
Wed, 06/14/23 - 10:25 am
Kura Oncology
ziftomenib
AML
stock offering
EHA
Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
BioSpace
Wed, 11/24/21 - 10:14 am
Kura Oncology
KOMET-001
KO-539
AML
patient deaths
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
BioSpace
Wed, 01/20/21 - 11:20 pm
cancer
oncology
Kura Oncology
personalized medicine
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
CP Wire
Wed, 05/2/18 - 07:21 pm
Kura Oncology
tipifarnib
patents
AML
PTCL
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
Wed, 05/2/18 - 10:01 am
Kura Oncology
tipifarnib
